[Breathing disorders as sequelae of therapy].
D000136:Acid-Base Equilibrium; D000319:Adrenergic beta-Antagonists / Q000009:adverse effects; D000368:Aged; D000900:Anti-Bacterial Agents / Q000009:adverse effects; D000996:Antitussive Agents / Q000009:adverse effects; D002021:Buffers / Q000009:adverse effects; D004361:Drug Tolerance; D064420:Drug-Related Side Effects and Adverse Reactions; D006801:Humans; D006993:Hypnotics and Sedatives / Q000009:adverse effects; D008297:Male; D008875:Middle Aged; D009020:Morphine / Q000009:adverse effects; D012119:Respiration / Q000187:drug effects; D012121:Respiration, Artificial / Q000009:adverse effects; D012129:Respiratory Function Tests; D012131:Respiratory Insufficiency / Q000139:chemically induced*
D000319:Adrenergic beta-Antagonists; D000900:Anti-Bacterial Agents; D000996:Antitussive Agents; D002021:Buffers; D006993:Hypnotics and Sedatives; D009020:Morphine
Atemstörungen als Therapiefolge.